pancreatic cancer
Member A.R.CA.D Launches Calls for Pancreatic Cancer Projects in France
Digestive Cancers Europe Member A.R.CA.D launches calls for pancreatic cancer projects to help fight the disease
...
DiCE Member Codice Viola Helps Shift to Multidisciplinary Pancreatic Cancer Care
DiCE Member Codice Viola helps in the shift towards specialised pancreatic cancer care units in the Italian Lombardy Region
...
Promising Research Published for Early Detection of a Certain Pancreatic Cancer
Study published in ‘Gut’ finds new molecular signature that could help in identifying most common form of pancreatic cancer – PDA...
Welcome to Our New Italian Member – Codice Viola
We are very pleased to give a warm and hearty welcome to Codice Viola into our Digestive Cancers Europe network of Members.
...
Research Finds Viable Marker for the Early Diagnosis of Most Common Type of Pancreatic Cancer
Teams of researchers from Spain have identified a new viable marker for early diagnosis in the most common type of pancreatic cancer, pancreatic du...
Raising Awareness of Pancreatic Cancer on November 18
Join us on November 18 to raise awareness of pancreatic cancer on World Pancreatic Cancer Day
...
FDA Approves Drug for Pancreatic Cancer Treatment
There’s a new treatment option for some patients with pancreatic cancer — those who carry a specific genetic mutation can now be treated wi...
Does Type 2 Diabetes Increase the Risk of Pancreatic Cancer?
Pancreatic cancer is a form of cancer that occurs when cells are produced in the pancreas in an uncontrolled manner. Like all cancers, the earlier ...
Pancreatic cancer drug reaches Phase III status
A pancreatic cancer drug discovered in professors Paul Bingham and Zuzana Zachar’s lab in the Department of Biochemistry and Cell Biology at Ston...
Overcoming resistance in pancreatic cancer
In pancreatic cancer cells’ struggle to survive, the cells choose alternative routes when their main pathways are blocked by drugs. Researche...
